Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies

Paula Müller,Heiko Lemcke,Robert David

DOI: https://doi.org/10.1159/000492704

2018-01-01

Cellular Physiology and Biochemistry

Abstract:A large number of clinical trials have shown stem cell therapy to be a promising therapeutic approach for the treatment of cardiovascular diseases. Since the first transplantation into human patients, several stem cell types have been applied in this field, including bone marrow derived stem cells, cardiac progenitors as well as embryonic stem cells and their derivatives. However, results obtained from clinical studies are inconsistent and stem cell-based improvement of heart performance and cardiac remodeling was found to be quite limited. In order to optimize stem cell efficiency, it is crucial to elucidate the underlying mechanisms mediating the beneficial effects of stem cell transplantation. Based on these mechanisms, researchers have developed different improvement strategies to boost the potency of stem cell repair and to generate the “next generation” of stem cell therapeutics. Moreover, since cardiovascular diseases are complex disorders including several disease patterns and pathologic mechanisms it may be difficult to provide a uniform therapeutic intervention for all subgroups of patients. Therefore, future strategies should aim at more personalized SC therapies in which individual disease parameters influence the selection of optimal cell type, dosage and delivery approach.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the treatment of cardiovascular diseases (CVDs), especially the problem of irreversible damage to heart tissue. Although current drug and interventional treatment methods can improve symptoms and slow down adverse cardiac remodeling, they cannot solve the fundamental problem of permanent loss of myocardial tissue. Therefore, stem cell therapy, as an innovative treatment method, has the potential to change the traditional treatment of cardiovascular diseases by stimulating the regeneration of damaged myocardium.

Specifically, this paper explores the following aspects:

1. **Effects and limitations of stem cell therapy**: Although many clinical trials have shown that stem cell therapy shows promise in the treatment of cardiovascular diseases, the results are inconsistent, and the improvement in cardiac function and structural remodeling based on stem cells is rather limited. In order to optimize the effect of stem cell therapy, it is necessary to clarify the mechanisms that mediate the beneficial effects of stem cell transplantation.

2. **Different types of stem cells and their applications**: The paper reviews different types of stem cells used for heart regeneration, including bone marrow - derived stem cells, cardiac progenitor cells, embryonic stem cells and their derivatives, etc., and discusses the advantages and disadvantages of each cell type.

3. **Strategies to improve the efficacy of stem cell therapy**: Due to the limited effect of existing stem cell therapy, researchers have developed a variety of improvement strategies to enhance the ability of stem cells to repair, thereby generating "next - generation" stem cell treatment products.

4. **The necessity of personalized treatment**: Given the complexity of cardiovascular diseases and diverse pathological mechanisms, future research should be dedicated to more personalized stem cell therapy, so that individual disease parameters can influence the selection of the optimal cell type, dosage, and delivery method.

In summary, this paper aims to systematically evaluate the current status of stem cell therapy in the treatment of cardiovascular diseases and propose improvement strategies in order to achieve better treatment results.